Can a hearse carrying a corpse drive in the carpool lane Baby Bottle Makers Ditch BPA?”
Baby Bottle Makers Ditch BPA Six Major Makers of Baby Bottles Say They’ll Stop Using Bisphenol A in Plastic Baby Bottles By Miranda Hitti WebMD Health News Reviewed by Louise Chang, MD March 6, 2009 — The top six makers of baby bottles in the U.S. have agreed to stop using the polycarbonate plastic chemical bisphenol A (BPA) in their bottles. Connecticut’s Attorney General Richard Blumenthal announced that news yesterday. The six bottle makers who agreed to stop using BPA are Avent, Disney First Years, Gerber, Dr. Brown, Playtex, and Evenflo. In a news release, Blumenthal says he and the attorneys general of Delaware and New Jersey wrote to those companies last October to ask that they stop using BPA in baby bottles because of concerns about possible health risks. Blumenthal calls the companies’ voluntary decision to quit using BPA “a major public health victory.” Blumenthal also says he is seeking “complete prohibition” of BPA in any product marketed for use by children younger than
Baby Bottle Makers Ditch BPA March 10, 2009 — The top six makers of baby bottles in the U.S. have agreed to stop using the polycarbonate plastic chemical bisphenol A (BPA) in their bottles. Connecticut’s Attorney General Richard Blumenthal announced that news yesterday. The six bottle makers who agreed to stop using BPA are Avent, Disney First Years, Gerber, Dr. Brown, Playtex, and Evenflo. In a news release, Blumenthal says he and the attorneys general of Delaware and New Jersey wrote to those companies last October to ask that they stop using BPA in baby bottles because of concerns about possible health risks. Blumenthal calls the companies’ voluntary decision to quit using BPA “a major public health victory.” Blumenthal also says he is seeking “complete prohibition” of BPA in any product marketed for use by children younger than 3, in containers of infant formula and baby food, and any reusable food or beverage container if a safe alternative is available. The FDA is studying bisphe
